Related references
Note: Only part of the references are listed.Progress in Nanoparticulate Systems for Peptide, Proteins and Nucleic Acid Drug Delivery
Stanislaw Slomkowski et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles
Ofra Ziv-Polat et al.
BIOMATERIALS (2010)
Neuroimmunomodulation in the Pathogenesis of Alzheimer's Disease
Inelia Morales et al.
NEUROIMMUNOMODULATION (2010)
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease
Wolfgang J. Streit et al.
ACTA NEUROPATHOLOGICA (2009)
Accumulation of tau induced in neurites by microglial proinflammatory mediators
Philipp Gorlovoy et al.
FASEB JOURNAL (2009)
Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring
Benny Perlstein et al.
NEURO-ONCOLOGY (2008)
A limited role for microglia in antibody mediated plaque clearance in APP mice
Monica Garcia-Alloza et al.
NEUROBIOLOGY OF DISEASE (2007)
The microglial networks of the brain and their role in neuronal network plasticity after lesion
Staffan Cullheim et al.
BRAIN RESEARCH REVIEWS (2007)
The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
Ryan A. Adams et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Evidence for synaptic stripping by cortical microglia
Bruce D. Trapp et al.
GLIA (2007)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy
TL Spires et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3β activation
YH Zhang et al.
FEBS LETTERS (2005)
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
IJM de Vries et al.
NATURE BIOTECHNOLOGY (2005)
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease
M Kitazawa et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats
T Green-Sadan et al.
EXPERIMENTAL NEUROLOGY (2005)
Microglia and neuroprotection: implications for Alzheimer's disease
WJ Streit
BRAIN RESEARCH REVIEWS (2005)
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
HG Lee et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway
RA Quintanilla et al.
EXPERIMENTAL CELL RESEARCH (2004)
Role of tau protein in both physiological and pathological conditions
J Avila et al.
PHYSIOLOGICAL REVIEWS (2004)
Cortical synaptic integration in vivo is disrupted by amyloid-β plaques
EA Stern et al.
JOURNAL OF NEUROSCIENCE (2004)
Microglia and inflammatory mechanisms in the clearance of amyloid β peptide
J Rogers et al.
GLIA (2002)
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
F Scherer et al.
GENE THERAPY (2002)
Neurotrophin secretion from cultured microglia
K Nakajima et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy
SR Rudge et al.
BIOMATERIALS (2000)
Tau dephosphorylation at tau-1 site correlates with its association to cell membrane
M Arrasate et al.
NEUROCHEMICAL RESEARCH (2000)
Share Paper
